top of page

Recent Posts

CRISPR Plus Drug Treatment Makes Neuroblastoma Responsive to Immunotherapy

Oct 29, 2024

Researchers in Italy and Australia report a triple combination strategy involving CRISPR that boosts the response of neuroblastoma to immunotherapy.

Read more: https://crisprmedicinenews.com/news/crispr-plus-drug-treatment-makes-neuroblastoma-responsive-to-immunotherapy/

Comments

Children with congenital heart defects found to have poorer survival following cancer diagnosis

‘Overwhelming evidence’ that common products are fuelling huge surge in childhood cancer cases, scientists warn

Understanding common challenges in childhood cancer treatment

Obesity at diagnosis predicts poorer survival for children with cancer

Bone Mineral Density Deficits Prevalent Among Childhood Cancer Survivors

Cutting-edge immunotherapy offers hope for relapsed brain tumors

AYA Patients With Cancer, ‘In Between’ Kids and Adults, Face Unique Concerns

New Research Shows Inherited Genetic Variants Increase Risk of Certain Pediatric Cancers

Menin inhibitor clinical trial puts pediatric leukemia patient in remission

Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine

Archive

Search By Tags

bottom of page